Profiles of serum proteins and free amino acids associated with chloroquine retinopathy

Acta Ophthalmologica Scandinavica

Volumn 76, Issue 4, 1998, Pages 422-430

  El Sayed, Nagla K ^a   Abdel Khalek, Laila R ^b   Gaafar, Khadiga M ^a   Hanafy, Laila K ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

Author keywords

Chloroquine: serum proteins; Free amino acids; Rabbits; Retinopathy

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; ARGININE; CHLOROQUINE; GLUTAMINE; GLUTARALDEHYDE; ORNITHINE; SERINE; SERUM ALBUMIN; SERUM GLOBULIN; TAURINE; TRYPTOPHAN; TYROSINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTROPHORESIS; HYPOPROTEINEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; RETINA; RETINOPATHY;

EID: 0031817250     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.1998.760407.x     Document Type: Article

References (44)

1. Abraham R & Hendy RJ (1970a): Effects of chronic chloroquine treatment on lysosomes of rat liver cells. Exp Mol Path 12: 148-159.
2. Abraham R & Hendy RJ (1970b): Irreversible lysosomal damage induced by chloroquine in the retinae of pigmented and albino rats. Exp Mol Path 12: 185-200.
3. Bernstein HM & Ginsberg J (1964): The pathology of chloroquine retinopathy. Arch Ophthalmol 71: 238-245.
4. Berson EL (1970): Acute toxic effects of chloroquine on the cat retina. Invest Ophthalmol 9: 618-628.
5. Cohen MM & Orr H (1973): Absolute levels of some free amino acids in normal and biologically fractionated retinas. Invest Ophthalmol 12: 686-693.
6. Del Monte MA, Hu DN & Maumenee IH (1982): Selective ornithine toxicity to cultured human retinal pigment epithelium (abst.). Invest Ophthalmol Vis Sci (ARVO Suppl.) 22: 173.
7. Drenckhahn D & Lullmann-Rauch R (1978): Drug-induced retinal lipidosis. Differential susceptibilities of pigment epithelium and neuroretina toward several amphiphilic cationic drugs. Exp Mol Pathol 28: 360-371.
8. Fedorko ME, Hirsch JG & Cohn ZA (1968): Autophagic vacuoles produced in vitro. 1. Studies on cultured macrophages exposed to chloroquine. J Cell Biol 38: 377-391.
9. Francois J & Maudgal MC (1967): Experimentally induced chloroquine retinopathy in rabbits. Am J Ophthal 64: 886-893.
10. Gaafar KM, Abdel-Khalek LR, El-Sayed NK and Ramadan GA (1995): Lipidemic effect as a manifestation of chloroquine's retinotoxicity. Arzneim-Forsch./Drug Res. 45(11), 11, 1231-1235.
11. Glauert AM (1965): The fixation and embedding of biological specimen. In: Techniques for electron microscopy. D.H. Key, ed. Davis Co., Philadelphia, pp. 166-212.
12. Gleiser CA, Bay WW, Dukes TW, Brown RS, Read WR & Pierce KR (1968): Study of chloroquine toxicity and a drug-induced cerebrospinal lipodystrophy in swine. Am J Pathol 53(1): 27-45.
13. Gleiser CA, Dukes TW, Lawwill T, Read WK, Ray WW & Brown RS (1969): Ocular changes in swine associated with chloroquine toxicity. Am J Ophthal 67(3): 399-405.
14. Gonasun LM & Potts AM (1974): In vitro inhibition of protein synthesis in the retinal pigment epithelium by chloroquine. Invest Ophthalmol 13(2): 107-115.
15. th ed., Vol. 2, MacMillan Publishing Co., Inc. New York, pp. 981-983, 1000, 1582-1583.
16. Hallberg A, Naeser P & Andersson A (1990): Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of mouse. Acta Ophthalmol (Copenh) 68: 125-130.
17. Hayes KC & Carey RE (1975): Retinal degeneration associated with taurine deficiency in the cat. Science 138: 949-951.
18. Hollyfield JG (1983): Stimulation of the conditions of gyrate atrophy in vitro suppresses retinal protein synthesis. Trans Ophthalmol Soc UK 103: 385-389.
19. Hopkinson L & Jackson FL (1964): Effects of chloroquine on growth and metabolism. Nature 202: 27-29.
20. Homewood CA, Warhurst DC, Peters W & Baggaley VC (1972): Lysosomes, pH and the antimalarial action of chloroquine. Nature 235: 50-52.
21. Ivanina TA, Sakina NL, Lebedeva MN & Borovyagin YL (1989a) : A study of the mechanisms of chloroquine retinopathy. I. Chloroquine effect on lipid peroxidation of retina. Ophthalmic Res 21: 216-220.
22. Ivanina TA, Sakina NL, Lebedeva MN & Borovyagin VL (1989b): A study of the mechanisms of chloroquine retinopathy. II. Chloroquine effect on protein synthesis of retina. Ophthalmic Res 21: 272-277.
23. Jain NC (1986): Veterinary Haematology. Fourth Edition, Lea and Febiger, Philadelphia.
24. Kapur JN & Saxena HC (1972): Mathematical Statistics, S. Chand and Co. Ltd., Ram Nagar, New Delhi.
25. Kotaro O (1981): Experimental study of chloroquine retinopathy. Acta Soc Ophthalmol 85(7): 566-577.
26. Kuhn H, Keller P, Kovacs E & Steiger A (1981): Lack of correlation between melanin affinity and retinopathy in mice and cats treated with chloroquine of flunitrazepam. Graefes Arch Klin Ophthalmol 216: 177-190.
27. Kuwabara T, Ishikawa Y & Kaiser-Kupfer MI (1981): Experimental model of gyrate atrophy in animals. Ophthalmology 88: 331-334.
28. Legros J, Rosner I & Berger C (1973): Influence du niveau d'eclairement amblant sur les modifications oculaires induites par l'hydroxychloroquine chez le rat. Arch Ophthalmol 33: 417-424.
29. Loewy AG, Siekevitz P, Menninger JR & Gallant JAN (1991): Cell and Function. An integrated approach. Third edition. Saunders. College Publishing. Philadelphia, Toronto, London, Tokyo.
30. Mackenzie AH (1983): Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Amer J Med 75: 40-45.
31. Meier-Ruge W (1965): Experimental investigation of the morphogenesis of chloroquine retinopathy. Arch Ophthalmol 73: 540-544.
32. Monahen RH & Horns RC (1964): The pathology of chloroquine in the eye. Trans Amer Acad Ophthalmol 68: 40-44.
33. Ogonor JI (1993): The effect of chloroquine on plasma albumin, bilirubin, amylase, alkaline phosphatase and blood urea in man. J Clin Pharm Ther 18(3): 209-211.
34. Potts AM (1964a): Further studies concerning the accumulation of polycyclic compounds on uveal melanin. Invest Ophthalmol 3: 399-404.
35. Potts AM (1964b): The reaction of uveal pigment in vitro with polycyclic compounds. Invest Ophthalmol 3: 405-416.
36. Ramsey MS, Bloodworth JMB & Engerman RL (1970): Chloroquine retinopathy in the rabbits. Can J Ophthalmol 5: 264-273.
37. Reynolds ES (1963): The use of lead citrate at high pH as electronopaque stain in electron microscopy. J Cell Biol 17: 208.
38. Ritchie RF & Smith R (1976): Immunofixation. 1-General principles of application to agarose gel electrophoresis. Clin Chem 22: 497.
39. Rosenthal AR, Kolb H, Bergsman D, Huxsoll D & Hopkins JL (1978): Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 17: 1158-1175.
40. Sjostrand FS & Nilsson SE (1964): In: The rabbit in eye research (J.H. Prince, ed.) Thomas, Springfield, Illinois.
41. Smith RS & Berson EL (1971): Acute toxic effects of chloroquine on the cat retina: Ultrastructural changes. Invest Ophthalmol 10: 237-246.
42. Stauber WT, Hedge AM, Trout JJ & Schottelius BA (1981): Inhibition of lysosomal function in red and white skeletal muscles by chloroquine. Exp Neurol 71: 295-306.
43. Wetterholm DH & Winter FC (1964): Histopathology of chloroquine retinal toxicity. Arch Ophthalmol 71: 82-87.
44. Wisner-Gebhart AM, Brabec RK & Gray RH (1980): Morphometric studies of chloroquine-induced changes in hepatocytic organelles in the rat. Exp Mol Path 33: 144-152.